The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors.
Abstract Details
Late diagnosis of chronic liver disease in a community cohort (UK biobank): determinants and impact on subsequent survival
Public Health. 2020 Sep 26;187:165-171. doi: 10.1016/j.puhe.2020.07.017. Online ahead of print.
H Innes1, J R Morling2, E A Aspinall3, D J Goldberg3, S J Hutchinson3, I N Guha4
Author information
1Glasgow Caledonian University, School of Health and Life Sciences, Glasgow, UK; Health Protection Scotland, Glasgow, UK; Division of Epidemiology and Public Health, University of Nottingham, Nottingham, UK. Electronic address: Hamish.innes@gcu.ac.
2Division of Epidemiology and Public Health, University of Nottingham, Nottingham, UK; NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and the University of Nottingham, Nottingham, UK.
3Glasgow Caledonian University, School of Health and Life Sciences, Glasgow, UK; Health Protection Scotland, Glasgow, UK.
4NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and the University of Nottingham, Nottingham, UK.
PMID: 32992162
DOI: 10.1016/j.puhe.2020.07.017
Abstract
Background: Chronic liver disease (CLD) is frequently diagnosed at a late stage when prognosis is poor. We aimed to determine the patient factors associated with a late CLD diagnosis and its subsequent impact on survival to support early diagnosis initiatives.
Methods: We identified participants of UK biobank (UKB) study who developed first-time advanced CLD within 5 years. We identified the factors associated with late diagnosis via logistic regression and used survival analysis to measure the association between late CLD diagnosis and mortality risk.
Results: A total of 725 UKB participants developed first-time advanced CLD event within 5 years. In total, 83% of cases were diagnosed late. Late diagnosis was associated with aetiology; the odds of late diagnosis were 12 times higher for an individual with alcohol-related liver disease (ArLD) vs viral hepatitis (aOR:12.01; P < 0.001). Cumulative mortality 5 years after incident advanced CLD was 43.4% (95% CI:39.6-47.0). Late diagnosis was associated with a higher risk of postadvanced CLD mortality for patients with non-alcoholic fatty liver disease (aHR:2.18; 95% CI:0.86-5.51; P = 0.10), but not for other aetiologies.
Conclusions: Late CLD diagnosis varies according to aetiology and is highest for patients with ArLD and non-alcoholic fatty liver disease. The association between late diagnosis and postadvanced CLD mortality may also vary by aetiology.